Products
Oxiconazole was commercially available in the form of vaginal tablets (Oceral). It was approved in many countries since 1983. It was discontinued in 2017.
Structure and properties
Oxiconazole (C18H13Cl4N3O, Mr = 429.1 g/mol) is present in drugs as oxiconazole nitrate. It is an imidazole derivative.
Effects
Oxiconazole (ATC D01AC11, ATC G01AF17) has antifungal properties effective against dermatophytes, yeasts, other fungi, and some Gram-positive bacteria. The effects are due to inhibition of ergosterol synthesis by the fungi.
Indications
For the treatment of vaginal fungus.
Dosage
According to the professional information. The tablets are usually inserted deep into the vagina once as a single dose in the evening before sleeping. A second dose is possible if needed.
Contraindications
Oxiconazole is contraindicated in hypersensitivity. For complete precautions, see the drug label.
Interactions
There are no known interactions with other drugs.
Adverse effects
Possible adverse effects include local reactions.